Skip to main content
Erschienen in: The Journal of Headache and Pain 1/2014

Open Access 01.12.2014 | Meeting abstract

EHMTI-0379. Update of the uk post market pilot programme with single pulse transcranial magnetic stimulation (STMS) for the acute treatment of migraine

verfasst von: R Bhola, E Kinsella, F Ahmed, PJ Goadsby

Erschienen in: The Journal of Headache and Pain | Sonderheft 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Introduction

Some patients suffer disabling, frequent migraine without effective treatment as current pharmacological options may be contra-indicated, poorly tolerated or overused. Single pulse transcranial magnetic stimulation (sTMS) is a novel, CE marked, non-drug treatment for migraine.

Aim

To evaluate the patient response to sTMS in open outpatient settings at UK headache clinics, and to assess the impact of sTMS over three months.

Methods

Clinicians selected patients and prescribed the device. Migraine patients with and without aura treating with sTMS had an initial review and training call (n = 304) with a headache nurse and then participated in telephone surveys at week six (n = 157) and week twelve during a 3-month treatment period (n= 122; episodic, n = 42; chronic, n = 80). Patient outcomes were documented, anonymised and analyzed and are presented here.

Results

In total 122 (35%) patients have been using the device for a minimum of three months and completed surveys. Of these, 89 (73%) reported a reduction or alleviation of pain. 101 (83%) were also using an acute medication at the time of prescription. Of these, 69 (68%) reported a reduction in the number of days of medications use. The treatment was well tolerated with no serious or unanticipated adverse events reported.

Conclusions

sTMS may be a valuable addition to options for the treatment of both episodic and chronic migraine. This device is safe to use in clinical practice and has reliable, reproducible effects on migraine over time.
The UK Pilot Programme was supported by eNeura Therapeutics.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://​creativecommons.​org/​licenses/​by/​4.​0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Metadaten
Titel
EHMTI-0379. Update of the uk post market pilot programme with single pulse transcranial magnetic stimulation (STMS) for the acute treatment of migraine
verfasst von
R Bhola
E Kinsella
F Ahmed
PJ Goadsby
Publikationsdatum
01.12.2014
Verlag
Springer Milan
Erschienen in
The Journal of Headache and Pain / Ausgabe Sonderheft 1/2014
Print ISSN: 1129-2369
Elektronische ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-M2

Weitere Artikel der Sonderheft 1/2014

The Journal of Headache and Pain 1/2014 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.